These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6653617)

  • 41. Overview on pharmacokinetics of nimodipine in healthy volunteers and in patients with subarachnoid hemorrhage.
    Rämsch KD; Ahr G; Tettenborn D; Auer LM
    Neurochirurgia (Stuttg); 1985 May; 28 Suppl 1():74-8. PubMed ID: 4010869
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Benoxaprofene: pharmacokinetic profile in the normal subject and patients with renal insufficiency; evaluation of anticipated serum levels].
    Brogard JM; Audhuy B; Spach MO
    Schweiz Med Wochenschr; 1981 Feb; 111(6):197-201. PubMed ID: 7221526
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Pharmacokinetic studies on ceftazidime in neonates].
    Nishimura T; Tabuki K; Takashima T
    Jpn J Antibiot; 1986 Aug; 39(8):2155-61. PubMed ID: 3540347
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The comparative activity of twelve 4-quinolone antimicrobials against Haemophilus influenzae and Streptococcus pneumoniae.
    Ridgway GL; O'Hare MD; Felmingham D; Grüneberg RN
    Drugs Exp Clin Res; 1985; 11(4):259-62. PubMed ID: 2941258
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antibacterial activity after a single-dose of norfloxacin, ofloxacin and pipemidic acid detected in urine of volunteers.
    Cruciani M; Monzillo V; Navarra A; Tinelli C; Concia E
    Drugs Exp Clin Res; 1988; 14(8):533-7. PubMed ID: 3150350
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Antibacterial in-vitro activity of pipemidic acid and nalidixic acid (author's transl)].
    Peters G; Freiesleben H; Marre R; Metz H; Tannenberg H; Pulverer G
    Dtsch Med Wochenschr; 1979 Jun; 104(26):946-8. PubMed ID: 110574
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pharmacokinetic properties of enrofloxacin in rabbits.
    Broome RL; Brooks DL; Babish JG; Copeland DD; Conzelman GM
    Am J Vet Res; 1991 Nov; 52(11):1835-41. PubMed ID: 1664673
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of low-dose cinoxacin therapy and placebo in the prevention of recurrent urinary tract infections.
    Scheckler WE; Burt RA; Paulson DF
    J Fam Pract; 1982 Nov; 15(5):901-4. PubMed ID: 6752331
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A comparative study of pipemidic acid and nitrofurantoin in the treatment of uncomplicated urinary tract infections.
    Meyer EC; Schoeman HS
    S Afr Med J; 1987 Nov; 72(10):663-5. PubMed ID: 3686263
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Flomoxef in neonates and young infants; clinical efficacy, pharmacokinetic evaluation and effect on the intestinal bacterial flora].
    Fujita K; Murono K; Saijyo M; Kakuya F; Yoshioka H; Maruyama S; Sakata H; Hiramoto A; Inyaku F
    Jpn J Antibiot; 1991 Nov; 44(11):1216-27. PubMed ID: 1784072
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Clinical study on long-term cinoxacin therapy for outpatients with chronic complicated urinary tract infections].
    Matsumoto J; Yamasaki Y; Katoh M; Tada S
    Hinyokika Kiyo; 1985 May; 31(5):895-900. PubMed ID: 4050634
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In vitro synergistic activity of some chinolinic compounds combined with beta-lactam antibiotics against gram-positive and gram-negative clinical isolates.
    Ravagnan G; Piccolomini R; Speciale AM; Russo G; Renzini G
    Chemotherapy; 1985; 31(3):191-9. PubMed ID: 3996087
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparative in vitro activity of ciprofloxacin and five other quinoline derivatives against gram-negative isolates.
    Galante D; Pennucci C; Esposito S; Barba D
    Drugs Exp Clin Res; 1985; 11(5):331-4. PubMed ID: 2941260
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Bacteriological, pharmacokinetic and clinical studies on sulbactam/cefoperazone in the pediatric field].
    Fujii R; Meguro H; Arimasu O; Mashiko J; Tajima T; Nonaka C; Nagamatsu I; Sato Y; Honjo T; Watanabe A
    Jpn J Antibiot; 1984 Dec; 37(12):2427-56. PubMed ID: 6098739
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Fundamental and clinical studies on cefixime (5% granules) in the pediatric field].
    Toyonaga Y; Sugita M; Nakamura H; Joh K; Takahashi T; Kurosu Y; Hori M
    Jpn J Antibiot; 1986 Apr; 39(4):1055-75. PubMed ID: 3761537
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Pipemidic acid--an alternative in the oral treatment of urinary tract infections and prostatitis].
    Bischoff W
    Fortschr Med; 1982 Dec; 100(47-48):2234-6. PubMed ID: 7160818
    [No Abstract]   [Full Text] [Related]  

  • 57. [Long-term cinoxacin therapy for chronic complicated urinary tract infection].
    Ueyama H
    Hinyokika Kiyo; 1984 Jun; 30(6):849-55. PubMed ID: 6485978
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Study on the use of cefotiam in neonates].
    Iwai N; Taneda Y; Shibata M; Mizoguchi F; Nakamura H; Katayama M; Tauchi N; Kawamura M; Ozaki T; Ichikawa T
    Jpn J Antibiot; 1986 Sep; 39(9):2436-49. PubMed ID: 3467085
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Frequency and expression of mutational resistance to the 4-quinolone antibacterials.
    Smith JT
    Scand J Infect Dis Suppl; 1986; 49():115-23. PubMed ID: 3547618
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Studies on distribution of two nalidixic acid analogs in otorhinolaryngological field.
    Murai K; Baba S
    Auris Nasus Larynx; 1982; 9(1):45-52. PubMed ID: 6217806
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.